A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
California-Based Science Corporation Acquires Pixium Vision’s Prima Implant
Author: Joan McKenna
Science Corporation, of Alameda, California, reported April 25 that it had acquired the IP and related assets for the Prima retinal implant, developed by Pixium Vision SA, of France. Terms of the deal were not announced. The acquisition was approved as part of a proceeding in the Paris Commercial Court, after Pixium was placed in liquidation. Science said it would continue to develop the Prima in tandem with its own retinal implant, the Science Eye. Pixium’s system targets the retinal ganglio...
Purchasing one of the following products will open up access to this article's content, which is also available in each comprehensive report/subscription.